{"DataElement":{"publicId":"7341050","version":"1","preferredName":"Prior Therapy Administration Wilms Tumor Category","preferredDefinition":"Information related to the Wilms tumor that prior therapy was administered.","longName":"DSE_PRIOR_TX_WT_CAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3187608","version":"1","preferredName":"Prior Therapy Administration","preferredDefinition":"information related to the prior therapy administered.","longName":"PRIOR_TX_ADMIN","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206408","version":"1","preferredName":"Prior Therapy","preferredDefinition":"Earlier in time or order.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25629:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F42E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320521","version":"1","preferredName":"Administration","preferredDefinition":"The act of administration.","longName":"C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-053F-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AE04853-FD8B-DB29-E040-BB89AD433D09","latestVersionIndicator":"Yes","beginDate":"2011-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7341045","version":"1","preferredName":"Wilms Tumor Category","preferredDefinition":"Wilms tumor categories.","longName":"7341045v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1000","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Relapsed FHWT","valueDescription":"Relapsed FHWT","ValueMeaning":{"publicId":"7341046","version":"1","preferredName":"Relapsed FHWT","longName":"7341046","preferredDefinition":"Relapsed favorable histology Wilms tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-069B-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B34302-06B4-552F-E053-4EBD850A9FD8","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Initial presentation of FHWT in patients who subsequently relapse","valueDescription":"Initial presentation of FHWT in patients who subsequently relapse","ValueMeaning":{"publicId":"7341047","version":"1","preferredName":"Initial presentation of FHWT in patients who subsequently relapse","longName":"7341047","preferredDefinition":"Initial presentation of favorable histology Wilms tumor in patients who subsequently relapse","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-06BE-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B34302-06D7-552F-E053-4EBD850A9FD8","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Newly diagnosed DAWT initially thought to be FHWT","valueDescription":"Newly diagnosed DAWT initially thought to be FHWT","ValueMeaning":{"publicId":"7341048","version":"1","preferredName":"Newly diagnosed DAWT initially thought to be FHWT","longName":"7341048","preferredDefinition":"Newly diagnosed diffuse anaplastic Wilms tumor initially thought to be favorable histology Wilms tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-06E1-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B34302-06FA-552F-E053-4EBD850A9FD8","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Newly diagnosed DAWT","valueDescription":"Newly diagnosed DAWT","ValueMeaning":{"publicId":"7341049","version":"1","preferredName":"Newly diagnosed DAWT","longName":"7341049","preferredDefinition":"Newly diagnosed diffuse anaplastic Wilms tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-0704-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B34302-071D-552F-E053-4EBD850A9FD8","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7341044","version":"1","preferredName":"Wilms Tumor Category","preferredDefinition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C3267:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wilms Tumor","conceptCode":"C3267","definition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-0674-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B34302-0685-552F-E053-4EBD850A9FD8","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"GALITG","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If prior to enrollment (Baseline), was procedure for treatment or diagnosis of:","url":null,"context":"COG"},{"name":"Was prior therapy for treatme","type":"Preferred Question Text","description":"Was prior therapy for treatment of:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B28B88-7937-55D8-E053-4EBD850A8836","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"KUMMEROA","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":"2023.5.11 Human readable def added. ak","unresolvedIssues":null,"deletedIndicator":"No"}}